FDA Approves New Alzheimer’s Drug, but There Are Lingering Questions
[ad_1] Image: Shutterstock (Shutterstock) The Food and Drug Administration on Friday granted the conditional approval of a new treatment for people with early Alzheimer’s disease: the antibody-based…